LAQV, REQUIMTE, Laboratory of Bromatology and Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Polo III, Azinhaga de Stª Comba, 3000-548 Coimbra, Portugal.
Molecules. 2020 Feb 25;25(5):1026. doi: 10.3390/molecules25051026.
Potential risks associated with releases of human pharmaceuticals into the environment have become an increasingly important issue in environmental health. This concern has been driven by the widespread detection of pharmaceuticals in all aquatic compartments. Therefore, 22 pharmaceuticals, 6 metabolites and transformation products, belonging to 7 therapeutic groups, were selected to perform a systematic review on their source, fate and occurrence in different aquatic compartments, important issues to tackle the Water Framework Directive (WFD). The results obtained evidence that concentrations of pharmaceuticals are present, in decreasing order, in wastewater influents (WWIs), wastewater effluents (WWEs) and surface waters, with values up to 14 mg L for ibuprofen in WWIs. The therapeutic groups which presented higher detection frequencies and concentrations were anti-inflammatories, antiepileptics, antibiotics and lipid regulators. These results present a broad and specialized background, enabling a complete overview on the occurrence of pharmaceuticals in the aquatic compartments.
与人类药品向环境中释放相关的潜在风险已成为环境健康领域一个日益重要的问题。这种关注是由所有水生环境中都检测到药品引起的。因此,选择了 22 种药品、6 种代谢物和转化产物,属于 7 种治疗组,以对其在不同水生环境中的来源、命运和出现进行系统审查,这是解决《水框架指令》(WFD)的重要问题。所获得的结果表明,药品的浓度存在于废水进水(WWIs)、废水出水(WWEs)和地表水中,依序递减,在 WWIs 中布洛芬的浓度高达 14 毫克/升。检测频率和浓度较高的治疗组是抗炎药、抗癫痫药、抗生素和血脂调节剂。这些结果提供了广泛而专业的背景,使人们对药品在水生环境中的存在有了全面的了解。